跳至主要内容
临床试验/NCT05777161
NCT05777161已完成不适用

A Randomized-controlled Trial of Therapy for Children and Adolescents With Anxiety Disorders and Obsessive Compulsive Disorder (OCD)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2020年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
162
试验地点
2
主要终点
Change in symptom severity per blinded independent evaluator

研究概览

简要总结

The purpose of this study is to examine the effectiveness of parent coached exposure therapy (PCET) and standard cognitive behavioral therapy (CBT) in treating childhood anxiety disorders and obsessive compulsive disorder (OCD).

详细描述

The purpose of this study is to examine the effectiveness of parent coached exposure therapy (PCET) through baseline comparisons, to compare effectiveness of individual PCET and individual standard cognitive behavioral therapy (CBT), to compare efficiency of individual PCET and individual standard CBT, to compare effectiveness of group intensive PCET, individual PCET, and individual standard CBT, and acceptability.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Outcome assessors were blind to condition. The integrity of the blind was evaluated

入排标准

年龄范围
7 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have a DSM-5 anxiety disorder diagnosis, including generalized anxiety disorder, obsessive compulsive disorder, panic disorder, agoraphobia, separation anxiety disorder, social and specific phobias, as assessed on the relevant modules of the (MINI-Kids; (Sheehan et al., 2010) by study staff in the PADC.
  • Be appropriate for the PADC standard outpatient therapy program, and be interested in starting outpatient therapy,
  • Have the anxiety disorder as their primary diagnosis,
  • If taking a selective serotonin reuptake inhibitor, SNRI, tricyclic, or antipsychotic medication, had no medication changes made at least 8 weeks prior to initiating participation in the study and agree to no changes during the 12 weeks of the study.

排除标准

  • History of and/or current psychosis, autism, bipolar disorder, or current suicidality, or eating disorder as assessed during the initial clinical interview and all available clinical information.
  • Current positive diagnosis in the child's caregiver of mental retardation, psychosis, or other psychiatric disorders or conditions that would limit his/her ability to understand CBT and follow-through with treatment directives (based on clinical interview).
  • Secondary diagnosis of oppositional defiant disorder or major depression of sufficient severity to prevent anxiety treatment.
  • Severity of symptoms that warrant higher level of care (i.e. intensive, residential, IOP, inpatient)
  • Family is unable to attend weekly sessions (i.e. geographical or scheduling barriers)
  • History of good quality exposure or CBT.

结局指标

主要结局

Change in symptom severity per blinded independent evaluator

时间窗: Baseline, mid-treatment (after 6 sessions), post-treatment (approximately 14 weeks)

Measured by the Clinical Global Impression Scale (GCI-S) rating of severity of psychopathology ranging from 1 (not at all ill) to 7 (extremely ill), with a score of 1 or 2 reflecting no to minimal symptoms

Treatment efficiency

时间窗: post-treatment (approximately 14 weeks)

Number of appointments attended

次要结局

  • Change in anxiety symptoms per blinded independent evaluator(Baseline, mid-treatment (after 6 sessions), post-treatment (approximately 14 weeks))
  • Change in symptom severity per parent(Baseline, mid-treatment (after 6 sessions), post-treatment (approximately 14 weeks))
  • Change in symptom severity per child(Baseline, mid-treatment (after 6 sessions), post-treatment (approximately 14 weeks))

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephen Whiteside

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验